New insider activity at Cencora ( (COR) ) has taken place on June 20, 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
EVP Silvana Battaglia recently made headlines by selling 4,077 shares of Cencora stock, amounting to a significant transaction worth $1,212,499.
Recent Updates on COR stock
In the last 24 hours, Wells Fargo upgraded Cencora’s stock rating to Overweight from Equal Weight, raising the price target from $274 to $337. This upgrade is attributed to a robust industry backdrop and high estimate achievability, coupled with Cencora’s reduced exposure to macroeconomic and policy risks. Wells Fargo’s estimates align with the consensus but factor in slower U.S. healthcare growth and potential impacts from M&A-driven customer loss, suggesting an upside potential in their estimates.
Spark’s Take on COR Stock
According to Spark, TipRanks’ AI Analyst, COR is a Outperform.
Cencora’s strong financial performance and positive earnings call results are key strengths, driving the overall score. Technical analysis suggests a neutral to slightly bullish trend, while valuation indicates potential overvaluation, which slightly tempers the overall score.
To see Spark’s full report on COR stock, click here.
More about Cencora
YTD Price Performance: 32.63%
Average Trading Volume: 1,777,929
Technical Sentiment Signal: Buy
Current Market Cap: $57.52B
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue